ASCO 2024: At a STAT event, oncology leaders spoke of advances that are turning old ideas like antibody-drug conjugates into broadly useful cancer drugs.
Comments
( ゚Д゚)
There's nothing here…
ASCO 2024: At a STAT event, oncology leaders spoke of advances that are turning old ideas like antibody-drug conjugates into broadly useful cancer drugs.